NYSE: BMY

Price$54.78 Change +0.19 %Change +0.35% Volume: 26,861,211 20 minute delay February 21, 2017

SEC Filings

Date Filing Description Download
Nov 30, 2001 8-K Current report filing
Nov 15, 2001 10-Q Quarterly Report
Nov 14, 2001 3 Initial Statement of Beneficial Ownership
Nov 14, 2001 10-Q Quarterly Report
Nov 01, 2001 SC TO-T/A Amended tender offer statement by Third Party
Oct 29, 2001 SC TO-T/A Amended tender offer statement by Third Party
Oct 26, 2001 SC TO-T/A Amended tender offer statement by Third Party
Oct 12, 2001 8-K Current report filing
Oct 12, 2001 SC TO-T/A Amended tender offer statement by Third Party
Sep 28, 2001 SC TO-T Tender offer statement by Third Party
Sep 26, 2001 424B5 Prospectus filed pursuant to Rule 424(b)(5)
Sep 25, 2001 8-K/A Amended Current report filing
Sep 25, 2001 8-K Current report filing
Sep 24, 2001 8-K/A Amended Current report filing
Sep 21, 2001 424B3 Prospectus filed pursuant to Rule 424(b)(3)
Sep 20, 2001 SC TO-C Written communication relating to an issuer or third party
Sep 20, 2001 8-K/A Amended Current report filing
Sep 19, 2001 8-K Current report filing
Aug 15, 2001 10-Q Quarterly Report
Aug 14, 2001 10-Q Quarterly Report
Aug 09, 2001 S-3/A Securities Registration Statement (simplified form)
Jul 19, 2001 S-8 Securities Registration: Employee Benefit Plan
Jul 19, 2001 S-3 Securities Registration Statement (simplified form)
Jul 03, 2001 11-K Annual Report of Employee Stock Plans
Jul 02, 2001 11-K Annual Report of Employee Stock Plans
Jun 08, 2001 8-K Current report filing
May 16, 2001 10-Q Quarterly Report
Apr 02, 2001 10-K Annual Report
Mar 19, 2001 AR/S Paper Annual Report to Security Holders
Mar 16, 2001 DEF 14A Proxy Statement (definitive)
Feb 13, 2001 SC 13G Statement of Ownership
Jan 25, 2001 8-K Current report filing

Materials on this website may contain information about the Company’s future plans and prospects that constitute forward-looking statements for purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are based on current expectations and involve inherent risks and uncertainties, including factors that could delay, divert or change any of them, and could cause actual outcomes and results to differ materially from current expectations. No forward-looking statement can be guaranteed. Forward-looking statements contained on this website should be evaluated together with the many uncertainties that affect Bristol-Myers Squibb's business, particularly those identified in the cautionary factors discussion in the company’s most recent annual report on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K. These documents are available from the Securities and Exchange Commission, the Bristol-Myers Squibb website or from Bristol-Myers Squibb Investor Relations.

In addition, any information contained on this website was current as of the date presented and should not be relied upon as representing our estimates as of any subsequent date. While we may elect to update forward-looking statements at some point in the future, we specifically disclaim any obligation to do so, even if our estimates change, whether as a result of new information, future events or otherwise. Consequently, the company will not update the information contained on the website and investors should not rely upon the information as current or accurate after the presentation date. The website may also contain certain non-GAAP financial measures, adjusted to include certain costs, expenses, gains and losses and other specified items. Reconciliations of these non-GAAP financial measures to the most comparable GAAP measures for a particular quarterly period are available on the company’s website at www.bms.com.